Literature DB >> 26537651

[Safety Evaluation of Rare Sugar Syrup: Single-dose Oral Toxicity in Rats, Reverse Mutation Assay, Chromosome Aberration Assay, and Acute Non-Effect Level for Diarrhea of a Single Dose in Humans].

Takako Yamada1, Tetsuo Iida, Satoshi Takamine, Noriko Hayashi, Kazuhiro Okuma.   

Abstract

The safety of rare sugar syrup obtained from high-fructose corn syrup under slightly alkaline conditions was studied. Mutagenicity of rare sugar syrup was assessed by a reverse mutation assay using Salmonella typhimurium and Escherichia coli, and an in vitro chromosomal aberration assay using Chinese hamster lung cell line (CHL/IU). No mutagenicity of rare sugar syrup was detected under these experimental conditions. Oral administration of single dose (15,000 mg/kg) of rare sugar syrup to rats caused no abnormalities, suggesting no adverse effect of rare sugar syrup. In humans, the acute non-effect level of rare sugar syrup for causing diarrhea was estimated as 0.9 g/kg body weight as dry solid base in both males and females.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26537651     DOI: 10.3358/shokueishi.56.211

Source DB:  PubMed          Journal:  Shokuhin Eiseigaku Zasshi        ISSN: 0015-6426            Impact factor:   0.464


  1 in total

1.  D‑allose enhances the efficacy of hydroxychloroquine against Lewis lung carcinoma cell growth by inducing autophagy.

Authors:  Kyoka Yamazaki; Masato Hoshi; Hiroyuki Tezuka; Nanaka Morita; Masaya Hirayama; Fumiaki Sato; Sayaka Yoshida; Kuniaki Saito
Journal:  Oncol Rep       Date:  2022-05-11       Impact factor: 4.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.